Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,039,757

« Back to Dashboard

Which drugs does patent 10,039,757 protect, and when does it expire?

Patent 10,039,757 protects CABOMETYX and is included in one NDA.

This patent has thirty-one patent family members in sixteen countries.

Summary for Patent: 10,039,757

Title:	C-Met modulator pharmaceutical compositions
Abstract:	Pharmaceutical compositions and unit dosage forms comprising Compound I are disclosed. ##STR00001##
Inventor(s):	Wilson; Jo Ann (San Francisco, CA), Shah; Khalid (Half Moon Bay, CA)
Assignee:	Exelixis, Inc. (Alameda, CA)
Application Number:	15/426,804
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 10,039,757
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,039,757

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Exelixis Inc	CABOMETYX	cabozantinib s-malate	TABLET;ORAL	208692-001	Apr 25, 2016		RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF ADVANCED RENAL CELL CARCINOMA	➤ Sign Up
Exelixis Inc	CABOMETYX	cabozantinib s-malate	TABLET;ORAL	208692-002	Apr 25, 2016		RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF ADVANCED RENAL CELL CARCINOMA	➤ Sign Up
Exelixis Inc	CABOMETYX	cabozantinib s-malate	TABLET;ORAL	208692-003	Apr 25, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				TREATMENT OF ADVANCED RENAL CELL CARCINOMA	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 10,039,757

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	082252	➤ Sign Up
Australia	2011278950	➤ Sign Up
Australia	2016247044	➤ Sign Up
Australia	2018220045	➤ Sign Up
Brazil	112013000980	➤ Sign Up
Canada	2805645	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.